Targeted Precision Therapy

Targeted Precision Therapy is a therapeutic approach that belongs to the class of clinical interventions designed for developmental encephalopathies and is distinguished by its reliance on molecular, genetic, or neurobiological biomarkers to guide the selection and application of individualized treatments aimed at specific pathological mechanisms.

61

Publications

3.3K

Citations

616

Authors

239

Institutions

Publications per year

2017–2026

54

Authors

616

  1. JZ
    Jianxiang Zhang

    Army Medical University, China

    3 publications · 178 citations

    3

    h-index

  2. JS
    J. Silvio Gutkind

    National Institute of Dental and Craniofacial Research, United States

    3 publications · 214 citations

    3

    h-index

  3. CL
    Chenwen Li

    Army Medical University, China

    3 publications · 178 citations

    3

    h-index

  4. WP
    Wendan Pu

    Army Medical University, China

    2 publications · 84 citations

    2

    h-index

  5. AE
    Andrew E. Aplin

    Thomas Jefferson University, United States

    2 publications · 99 citations

    2

    h-index

1–5 of 616

Venues

  1. Clinical Cancer Research

    3 publications · 253 citations

    3

    h-index

  2. Nature Communications

    3 publications · 303 citations

    3

    h-index

  3. Journal of Controlled Release

    2 publications · 56 citations

    2

    h-index

  4. Molecular Cancer Therapeutics

    MCT · 2 publications · 186 citations

    2

    h-index

  5. Science Advances

    2 publications · 168 citations

    2

    h-index

1–5